67255-1-Ig

antibody from Proteintech Group

Targeting: NANOG FLJ12581, FLJ40451

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

67255-1-Ig

Provider

Proteintech Group

Product name

NANOG antibody

Antibody type

Monoclonal

Description

NANOG antibody (Cat. #67255-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse and has been validated for the following applications: WB,ELISA.

Reactivity

Human, Mouse

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

3A2E1

Vial size

20ul, 150ul

References

Submitted references

eNAMPT/Ac-STAT3/DIRAS2 Axis Promotes Development and Cancer Stemness in Triple-Negative Breast Cancer by Enhancing Cytokine Crosstalk Between Tumor-Associated Macrophages and Cancer Cells.

Zhang L, Wang L, Xu Z, Zhang X, Guan S, Liu Z, Gu S, Zhao L, Bai W, Li T, Zhao X
International journal of biological sciences 2025;21(5):2027-2047

---

SIX1 transmits signals for breast cancer progression via the ZEB1/IL6/STAT3 signaling axis.

Guo L, Rao Y, Song Y, Hu J, Luo Z, Sun S, Chen C, Kong D
Oncogene 2025 Sep;44(37):3493-3511

---

NCAPH-YAP1 interaction promotes breast cancer stemness and tumor progression.

Qiu C, Wei Y, Li J
Stem cell research & therapy 2025 Sep 25;16(1):494

---

POLR1F promotes proliferation and stemness of anaplastic thyroid cancer by activating F2R/p38 MAPK signaling.

Gong Y, Wang S, Fang Z, Hu X, Li Y, Che Y, Tan Z, Su B, Ge M, Pan Z
Biochimica et biophysica acta. Molecular cell research 2025 Jun;1872(5):119963

---

Dual-Action Tocilizumab-Conjugated Cisplatin Nanoparticles Overcome Chemoresistance and Metastasis in Non-Small-Cell Lung Cancer.

Wang Y, Wu F, Yang T, Li B, Wang H, Ye P, Li W
Pharmaceutics 2025 Jul 21;17(7)

---

Microspheres of stem cells from human exfoliated deciduous teeth exhibit superior pulp regeneration capacity.

Ding J, Sun Z, Ma L, Wang L, Liao Z, Liang L, Yang H, Mao R
Dental materials : official publication of the Academy of Dental Materials 2025 Jan;41(1):70-80

---

Dandelion extract suppresses the stem-like properties of triple-negative breast cancer cells by regulating CUEDC2/β-catenin/OCT4 signaling axis.

Deng X, Jiao Y, Hao H, Guo Z, An G, Zhang W, Xue D, Han S
Journal of ethnopharmacology 2025 Feb 27;342:119408

---

Integrated network pharmacology and experimental validation reveal EGFR/p53/Bcl-2-mediated anti-hepatocellular carcinoma effects of Zedoary Turmeric Oil.

Zhong M, Li Y, Wang H, Fan N, Chu X, Liu L, Zhao C, Sun Y, Zhang S, Fu H
Journal of ethnopharmacology 2025 Aug 29;352:120241

---

Hypoxic Cancer Cells-Derived Exosomes Strengthen the Development of Cancer Stem Cell-Like Properties Through Delivering LINC00665 in Thyroid Cancer Cells.

Zhou M, Peng C, Zhang Q, Tong Y
Cell biology international 2025 Apr;49(4):384-396

---

Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma.

Zhao Y, Xue S, Wei D, Zhang J, Zhang N, Mao L, Liu N, Zhao L, Yan J, Wang Y, Cai X, Zhu S, Roessler S, Ji J
Journal of experimental & clinical cancer research : CR 2024 Sep 6;43(1):255

---

Melatonin inhibits the stemness of head and neck squamous cell carcinoma by modulating HA synthesis via the FOSL1/HAS3 axis.

Luo X, Wang J, Chen Y, Zhou X, Shao Z, Liu K, Shang Z
Journal of pineal research 2024 Mar;76(2):e12940

---

The small nucleolar RNA SNORA51 enhances breast cancer stem cell-like properties via the RPL3/NPM1/c-MYC pathway.

Li S, Jin Z, Song X, Ma J, Peng Z, Yu H, Song J, Zhang Y, Sun X, He M, Yu X, Jin F, Zheng A
Molecular carcinogenesis 2024 Jun;63(6):1117-1132

---

Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression.

Zhu L, Tang N, Hang H, Zhou Y, Dong J, Yang Y, Mao L, Qiu Y, Fu X, Cao W
Cancer letters 2024 Apr 1;586:216611

---

Rab11-FIP4 interacts with ARF5 to promote cancer stemness in hepatocellular carcinoma.

Song F, Zhang Q, Lu X, Xu T, Hu Q, Hu X, Fan W, Zhang Y, Huang P
Journal of physiology and biochemistry 2023 Nov;79(4):757-770

---

NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.

Wang Y, Zhang L, Sun XL, Lu YC, Chen S, Pei DS, Zhang LS
Apoptosis : an international journal on programmed cell death 2023 Feb;28(1-2):233-246

---

Application of mPEG-CS-cRGD/Bmi-1RNAi-PTX nanoparticles in suppression of laryngeal cancer by targeting cancer stem cells.

Xu X, Zhou T, Wei X, Jiang X, Cao J
Drug delivery 2023 Dec;30(1):2180112

---

Antitumor Effect of Si-Jun-Zi Decoction on SGC7901 Gastric Cancer Cells by CMTM2 Activation.

Li X, Chen W, Miao L, Sun H, Gao X, Guo S, Zhang Y, Yang Y, Guo J
Evidence-based complementary and alternative medicine : eCAM 2022;2022:4675815

---

Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis.

Ding L, Yang Y, Lu Q, Qu D, Chandrakesan P, Feng H, Chen H, Chen X, Liao Z, Du J, Cao Z, Weygant N
International journal of molecular sciences 2022 Nov 1;23(21)

---

Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization.

Yuan Y, Yao H, Zhou M, Ma X, Zhou Y, Xu J, Niu M, Yin J, Zheng L, Xu S
Journal of medicinal chemistry 2022 Dec 8;65(23):15749-15769

---

The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer.

Lo UG, Chen YA, Cen J, Deng S, Luo J, Zhau H, Ho L, Lai CH, Mu P, Chung LWK, Hsieh JT
Clinical and translational medicine 2022 Aug;12(8):e978

---

Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions.

Chen X, Zhang Y, Qian W, Han L, Li W, Duan W, Wu Z, Wang Z, Ma Q
iScience 2021 Dec 17;24(12):103400

---

Limonin enhances the radiosensitivity of nasopharyngeal carcinoma cells via attenuating Stat3-induced cell stemness.

Gao L, Sang JZ, Cao H
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019 Oct;118:109366

---

Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.

Liu X, Huang J, Xie Y, Zhou Y, Wang R, Lou J
Medical science monitor : international medical journal of experimental and clinical research 2019 Nov 24;25:8905-8912